WHI, JAZZ, ABIO, LFBG, WNWG, MODC Have Been Removed From Naked Short List Today

BUYINS.NET, www.buyins.net, announced today that these select companies have been removed from the NASDAQ, AMEX and NYSE naked short threshold list: W Holding Company Inc. (NYSE: WHI), Jazz Pharmaceuticals Inc. (NASDAQ: JAZZ), Arca biopharma Inc. (NASDAQ: ABIO), Left Behind Games Inc. (OTCBB: LFBG), Wentworth Energy, Inc. (OTCBB: WNWG), Modern Technology Corporation (OTC: MODC). For a complete list of companies on the naked short list please visit our web site. To find the SqueezeTrigger Price before a short squeeze starts in any stock, go to www.buyins.net.

W Holding Company Inc. (NYSE: WHI) operates as the holding company for Westernbank Puerto Rico, which offers business and consumer financial services in Puerto Rico, the United States. It primarily engages in generating deposits and originating loans. The company's deposit products include savings deposits, time deposits, brokered deposits, individual retirement account deposits, and interest and non-interest bearing demand deposits. Its loan portfolio comprises commercial real estate mortgage, residential real estate mortgage, construction loans, and consumer loans, as well as commercial, industrial, and agricultural loans. W Holding Company also offers investment, trust, securities brokerage, and treasury services. In addition, the company operates as a general insurance agent, providing property, casualty, life, and disability insurance. As of December 31, 2007, it operated 49 bank branches, including 26 in the western and southwestern regions, 14 in the San Juan metropolitan area, 7 in the northeastern region, and 2 in the eastern region in Puerto Rico, as well as offers its services through online. The company was founded in 1958 and is based in Mayaguez, Puerto Rico. With 3.3 million shares outstanding and 604,100 shares declared short as of June 2009, there is no longer a failure to deliver in shares of WHI. According to quarterly data provided by the SEC, there were still 2,768,348 shares of WHI that were failing-to-deliver as of December 10, 2007.

Jazz Pharmaceuticals Inc. (NASDAQ: JAZZ) a specialty pharmaceutical company, develops and commercializes products for neurology and psychiatry primarily in the United States. The company's marketed products include Xyrem for the treatment of excessive daytime sleepiness and cataplexy in patients with narcolepsy; and Luvox CR for obsessive compulsive disorder and social anxiety disorder. Its product candidate in Phase III clinical trials comprise JZP-6 for the treatment of fibromyalgia. The company's other product candidates in clinical development comprises JZP-8, an intranasal formulation of clonazepam for the treatment of recurrent acute repetitive seizures in epilepsy patients who continue to have seizures while on stable anti-epileptic regimens; JZP-4, a controlled release formulation of an anticonvulsant for the treatment of epilepsy and bipolar disorder; and JZP-7 for the treatment of restless legs syndrome. Jazz Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Palo Alto, California. With 28.93 million shares outstanding and 241,800 shares declared short as of June 2009, there is no longer a failure to deliver in shares of JAZZ. According to quarterly data provided by the SEC, there were still 316,132 shares of JAZZ that were failing-to-deliver as of June 22, 2007.

Arca biopharma Inc. (NASDAQ: ABIO) a biopharmaceutical company, focuses on the development and commercialization of genetically-targeted therapies for heart failure and other cardiovascular diseases in the United States. The company's lead product candidate includes Gencaro, a pharmacologically beta-blocker and mild vasodilator for the treatment of chronic heart failure and other indications. It also focuses on the development of NU172, a short-acting anticoagulant used during medical or surgical procedures, which has completed Phase Ib clinical study. ARCA biopharma has a collaboration agreement with LabCorp to develop the Gencaro Test, a companion test for the genetic markers that predict clinical response to Gencaro. The company is headquartered in Broomfield, Colorado. With 7.57 million shares outstanding and 33,100 shares declared short as of June 2009, there is no longer a failure to deliver in shares of ABIO. According to quarterly data provided by the SEC, there were still 33,604 shares of ABIO that were failing-to-deliver as of November 30, 2005.


Left Behind Games Inc. (OTCBB: LFBG) engages in the development, publishing, and distribution of video games and related products in the United States. The company develops its video game products based on the Left Behind series of novels and products. Its primary product includes LEFT BEHIND: Eternal Forces, a real time strategy game played by one person or online by up to eight players on personal computers. The company sells its products through a direct-to-store distribution channel or through distributors to Christian booksellers association and inspirational marketplaces. It markets its products in North America, Australia, Canada, Singapore, and South Africa. Left Behind Games, Inc. was founded in 2002 and is based in Murrieta, California. With 209.1 million shares outstanding and 48,200 shares declared short as of June 2009, there is no longer a failure to deliver in shares of LFBG. According to quarterly data provided by the SEC, there were still 751,508 shares of LFBG that were failing-to-deliver as of May 19, 2008.

Wentworth Energy, Inc. (OTCBB: WNWG) engages in the exploration, development, drilling, and production of oil and gas properties in the United States. It has oil and gas interests in Anderson County, Freestone County, Jones County, and Leon County, Texas. The company is based in Palestine, Texas. With 67.42 million shares outstanding and an undisclosed short position, there is no longer a failure to deliver in shares of WNWG. According to quarterly data provided by the SEC, there were still 394,292 shares of WNWG that were failing-to-deliver as of April 18, 2007.

Modern Technology Corporation (OTC: MODC) supports private and public companies in the areas of business development, financing, product development, corporate strategy, corporate image and public relations, product distribution and marketing, and executive management consulting. The company, through its subsidiaries, also distributes audio and video solutions for home and mobile environments, including the HD-TV, Plasma TV, and LCD TV; and creates customized targeted online incentive programs, employee motivation campaigns, service award plans, and customer loyalty programs. The company was founded in 1982 and is based in Oxford, Mississippi. With 1.32 billion shares outstanding and an undisclosed short position, there is no longer a failure to deliver in shares of MODC. According to quarterly data provided by the SEC, there were still 503,529 shares of MODC that were failing-to-deliver as of August 16, 2007.

About BUYINS.NET

WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.


BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database of nearly 2,650,000,000 short sale transactions goes back to January 1, 2005, and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005, because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each month's short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money.

All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET may receive compensation in cash or shares from independent third parties or from the companies mentioned.

BUYINS.NET affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. Market commentary provided by Thomas Ronk.

BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.


You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.

Contact: Thomas Ronk, CEO www.buyins.net Tom@buyins.net +1-800-715-9999